March 11, 2026 9:30 PM
CDSCO Issues Advisory to Prevent Misleading Promotion of Prescription Drugs for Obesity
The Central Drugs Standard Control Organization (CDSCO) has issued an advisory to pharmaceutical manufacturers, importers, and marketing authorization holders to ensure strict compliance with the provisions of the Drugs and Cosmetics Act, 1940 and Rules, 1945 in the promotion and marketing of prescription medicines, particularly GLP-1 receptor agonists and similar drugs indicated for obesity and metabolic disorders. The advisory highlights concerns regarding certain promotional activities, incl...